CVS 1
CVS 1
CVS 1
- Each 2mmHg rise in systolic blood pressure associated with a 7% increased risk
of mortality from ischaemic heart disease and a 10% increased risk of mortality
from stroke.
Systolic pressure: the higher measurement when the
heart beats, pushing blood through the arteries
Endocrine disease:
- Cushings syndrome
- Thyroid disease
- Acromegaly
- Phaeochromocytoma
Malignant hypertension
Occurs when blood pressure rises rapidly
Severe hypertension (diastolic BP >120mmHg)
Fibrinoid necrosis microvascular damage with necrosis in
walls of small arteries and arterioles
Causes rapidly progressive end organ damage (renal
failure; heart failure)
Retinopathy - Changes in retina (cotton wool spots, hard
exudates, papilloedema, haemorrhages)
High risk of cerebral oedema and haemorrhage with
resultant hypertensive encephalopathy
Diagnosis
If the clinic blood pressure is 140/90 mmHg or higher,
offer ABPM (ambulatory blood pressure monitor) to
confirm the diagnosis of hypertension
If a person is unable to tolerate ABPM, HBPM (home
blood pressure monitor) is a suitable alternative
Cardiovascular risk assessment
QRISK2 is the recommended formal risk assessment tool
to assess CVD risk
online assessment tool for estimating the 10-year risk of
having a cardiovascular event, in people who do not
already have heart disease
Adults aged 85 years and over and those with existing
CVD, type 1 diabetes, chronic kidney disease or familial
hypercholesterolaemia should be considered to be at an
increased risk of CVD events without using QRISK2
NICE guideline
References:
http://ndt.oxfordjournals.org/content/16/6/1095.full
https://www.nice.org.uk/guidance/cg127
https://cks.nice.org.uk/hypertension-not-diabetic
Kumar and Clarks Clinical medicine
Davidsons Principles and Practice of Medicine
HYPOTENSION
Orthostatic/Postural hypotension
Hypovolemic shock
Cardiogenic shock